SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-016705
Filing Date
2024-01-26
Accepted
2024-01-26 16:06:01
Documents
12
Period of Report
2024-01-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d746856d8k.htm   iXBRL 8-K 23642
  Complete submission text file 0001193125-24-016705.txt   145123

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA veru-20240125.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20240125_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20240125_pre.xml EX-101.PRE 11260
6 EXTRACTED XBRL INSTANCE DOCUMENT d746856d8k_htm.xml XML 3383
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 24567760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)